Compare LYEL & AXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | AXL |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 745.5M | 795.3M |
| IPO Year | 2021 | 1999 |
| Metric | LYEL | AXL |
|---|---|---|
| Price | $23.39 | $7.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $25.00 | $7.31 |
| AVG Volume (30 Days) | 133.6K | ★ 2.7M |
| Earning Date | 11-12-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.55 |
| EPS | N/A | ★ 0.34 |
| Revenue | $41,000.00 | ★ $5,833,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.66 |
| P/E Ratio | ★ N/A | $22.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.65 | $3.00 |
| 52 Week High | $45.00 | $7.92 |
| Indicator | LYEL | AXL |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 73.02 |
| Support Level | $22.75 | $7.57 |
| Resistance Level | $25.12 | $7.85 |
| Average True Range (ATR) | 2.58 | 0.29 |
| MACD | -1.30 | 0.12 |
| Stochastic Oscillator | 3.85 | 94.03 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.